POST-SHUTDOWN SUPPLIER COMPARISON

SMART MD vs Peptide Sciences:
What changed, and what's better.

Peptide Sciences shut down in the 2025-2026 FDA enforcement wave. SMART MD survived it. Here's an honest comparison of what researchers lost — and what they gained.

PEPTIDE SCIENCES
Shut down · Oct 2025
StatusOFFLINE
COA verification1 lab (unspecified)
Compliance structureDTC marketing with therapeutic implications
Payment processingCut off by processors
Store credit recoveryLost — no recourse
Wholesale programLimited
SMART MD
Live · Founded 2024
StatusLIVE
COA verification3 independent U.S. labs
Compliance structureResearch-use-only, supplier-to-physician
Payment processingStripe (live, stable)
Migration credit10% match on documented lost credit
Wholesale programFull: CORE / SIGNAL / APEX / PARTNER
Browse 100+ Compounds →

Why SMART MD survived and Peptide Sciences didn't.

It wasn't about product quality. Both carried research-grade compounds. The difference was compliance structure — how the business was built around the regulatory reality.

What got Peptide Sciences shut down

  • Direct-to-consumer marketing with implied therapeutic benefits
  • Payment processors flagged the business model as compliance risk
  • Single-lab COA verification (when provided)
  • No formal supplier-to-physician compliance framework
  • Customer base was primarily individual consumers, not licensed researchers

Why SMART MD is still standing

  • Research-use-only labeling on every product, page, and shipment
  • Supplier-to-licensed-physician structure (same as Sigma-Aldrich)
  • 3-lab independent COA verification (HPLC + mass spec + LAL endotoxin)
  • Stripe payment processing — stable, compliant, not flagged
  • Customer base is licensed researchers and physician-led programs

FAQ — Switching from Peptide Sciences to SMART MD

Peptide Sciences ceased operations in late 2025 as part of the broader FDA enforcement wave that also shut down Amino Asylum, Paradigm, Royal Research, and Science.bio. The enforcement targeted suppliers making therapeutic claims and selling direct-to-consumer without adequate research-use compliance frameworks. Payment processors simultaneously cut off flagged vendors, stranding thousands of researchers with unfulfilled orders and unrecoverable store credit.

SMART MD carries most of the same research compounds Peptide Sciences offered — BPC-157, TB-500, GLP-1SM, GLP-2TZ, NAD+, Ipamorelin, Sermorelin, and 100+ more — with a key difference: every batch is verified by 3 independent U.S. laboratories (vs. Peptide Sciences' single-lab approach), and the business is structured as a supplier-to-licensed-physician operation that survived the exact regulatory wave that took Peptide Sciences down. For compounds not immediately in stock, our Vetted Lab Network can source any research peptide with the same 3-lab COA standard.

We can't directly honor credit from another company. But if you have documentation of lost credit ($50+), we'll match 10% of it as SMART MD credit on your first wholesale order, up to $500. Email a screenshot or order confirmation to info@smartmbservices.com with subject "migration credit."

The suppliers that got hit were making therapeutic claims, selling DTC without disclaimers, and operating outside compliance. SMART MD was built specifically to survive enforcement — research-use-only, 3-lab COA verified, supplier-to-licensed-physician. Same legal structure as Sigma-Aldrich, Cayman Chemical, and every major research chemical supplier. We're on the compliant side of the regulatory line.

Go to smartmdpeptides.com/verify, enter any lot number, and review the full 3-lab COA package — HPLC purity, mass spectrometry, LAL endotoxin. Compare it against what Peptide Sciences was providing. The documentation depth difference is typically obvious in 30 seconds.

Ready to switch?

Your supplier shut down. Your research didn't. 100+ compounds, 3-lab verified, ships in 1-2 days.

Browse Catalog → Wholesale Program Full Migration Guide